NIHR King's Clinical Research Facility, & SLaM Biomedical Research Centre, The Wolfson Sensory, Pain and Regeneration Centre (SPaRC), Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.
Department of Neurology, Queen Elizabeth Hospital, London, UK.
J Headache Pain. 2024 May 31;25(1):89. doi: 10.1186/s10194-024-01755-w.
Medication-overuse headache (MOH), which potentially involves 1-2% of the population, is defined as a headache, on ≥ 15 days a month affected, along with overuse of one or other acute attack medications. MOH presents with significant challenges in the headache community, particularly in clinical settings raising various questions about its pathophysiology. Through a review of the current literature and our clinical experience, we have explored the mechanisms through which MOH may occur, provide an understanding of the current state of treatment and detail some possible views on the understanding and treatment of this condition. We evaluate the variations in treatment methods offered globally and understanding of the disorder. Above all interventions, patient education is crucial, which is underscored by an analysis of the academic publications. Given the condition is preventable, early intervention is imperative and patient awareness is highlighted as key. Globally, there is no uniform treatment methodology, which may be advantageous as approaches need to take local circumstances into account.
药物过度使用性头痛(MOH),潜在地影响着人群中的 1-2%,定义为每月≥15 天头痛发作,并伴有一种或另一种急性发作药物的过度使用。MOH 在头痛患者中提出了重大挑战,特别是在临床环境中,提出了关于其病理生理学的各种问题。通过对当前文献和我们的临床经验的回顾,我们探讨了 MOH 可能发生的机制,了解了当前的治疗状况,并详细介绍了对这种疾病的理解和治疗的一些可能观点。我们评估了全球提供的治疗方法和对这种疾病的理解的变化。在所有的干预措施中,患者教育至关重要,这一点通过对学术出版物的分析得到了强调。鉴于这种情况是可以预防的,早期干预至关重要,患者意识是关键。在全球范围内,没有统一的治疗方法,这可能是有利的,因为方法需要考虑当地情况。